Sign in

Oana Sandulescu

@oana-sandulescu.bsky.social
110 followers 38 following 66 posts

ID Prof Dr at Carol Davila University and NIID Matei Bals

PostsRepliesMedia
Oana Sandulescu @oana-sandulescu.bsky.social · 08/10/2026
Just back from a PhD committee at @uio.no 🎓 Impressive RCT of ~20,000 participants showed: #HEV vaccine safe in adults but should be avoided before and during early pregnancy. And the timing: just a day after the Nobel Prize in Medicine announcement! lnkd.in/eiV97GCb
011
Reposted by Oana Sandulescu
ESWI @eswinfluenza.bsky.social · 05/10/2026
🗓️ 🕒 Save the date for #ESWI2027: The largest European-based influenza conference returns for its 11th edition in Valencia, 26-29 September 2027. Subscribe to our newsletter to be the first to receive updates: eswi.org/form/newslet...
032
Oana Sandulescu @oana-sandulescu.bsky.social · 03/10/2026
🍄 #BalkanFungus in 🇷🇴 - landmark meeting for #MedicalMycology I shared an update on #cryptococcus, from screening and early recognition to diagnosis & management. Early diagnosis can make all the difference 💙 Congratulations @efisg-escmid.bsky.social and the amazing Cluj team! @escmid.bsky.social
012
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 02/10/2026
Chronic liver disease can be destabilised by #influenza and other respiratory infections. Honored that our #ESGVH Chair, Prof. @oana-sandulescu.bsky.social joins the #ESWI Board to connect liver health, vaccination and respiratory prevention. @escmid.bsky.social @eswinfluenza.bsky.social
011
Oana Sandulescu @oana-sandulescu.bsky.social · 02/10/2026
A new #EUCIC #IPC cohort in Ljubljana 💫 Fantastic evolution in a program we were piecing together several years ago. #AMS take-home: Tailor your ab choice. Your AMS plan. To your country. Your setting. Your patient. Evidence travels. Good stewardship adapts. @escmid.bsky.social @eucic.bsky.social
021
Oana Sandulescu @oana-sandulescu.bsky.social · 25/09/2026
Truly honored to join #ESWI and to be part of such an exceptional group of board members&experts. Looking forward to contributing my expertise and exchanging ideas to advance influenza science and public health. Grateful for the opportunity. Excited for the work ahead. @eswinfluenza.bsky.social
012
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 18/09/2026
Honoured and proud that our Chair, Prof. @oana-sandulescu.bsky.social delivered a fantastic keynote at #ESCV2026 in Porto! “Practical ART decision-making in HIV-HBV coinfection” - a timely reminder that HBV status matters in ART decisions. #HIV #HBV @escvirology.bsky.social @escmid.bsky.social
031
Oana Sandulescu @oana-sandulescu.bsky.social · 18/09/2026
Friday morning = keynote time at #ESCV2026 in Porto! My keynote: Practical ART decision-making in HIV-HBV coinfection 4 patient trajectories 4 ART decisions 4 things to know The message? HBV matters. Thank you @escvirology.bsky.social 👏👏 @esgvh.bsky.social @escmid.bsky.social
112
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 13/09/2026
⏰ TIME TO REGISTER! 🌍 Major international experts in viral hepatitis - all in one place. Join ESGVH for 3 days covering hepatitis A–E, emerging viruses & challenging cases. 📅 27–29 Nov 2026 | 💻 Online 👉 Register now lnkd.in/e53ChGBN @escmid.bsky.social
011
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 10/09/2026
Starting in 3 hours! Join us: HCV Elimination: A Multi-society Perspective on Progress, Gaps and Next Steps 📅 10 September 2026 ⏰ 3 pm CEST 💻 Zoom 🔗 Participation is free. Register here: lnkd.in/e577hvey @aasldnews.bsky.social @idsainfo.bsky.social @inhsu.bsky.social @escmid.bsky.social
011
Oana Sandulescu @oana-sandulescu.bsky.social · 01/09/2026
A thought to carry into autumn 🍂 At #ESC2026, I was invited to discuss the cardioprotective role of high-dose flu vaccination for the elderly. A great example of ID&cardio shared responsibility for the same patient. Flu prevention is also CV prevention 💉❤️ @escardio.bsky.social @medscape.com
096
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 29/07/2026
Breakthroughs in #ViralHepatitis begin with shared commitment. Read below an excellent paper published in #Germs_MDPI by our valued #ESGVH EC leaders: Prof @oana-sandulescu.bsky.social, Prof M Maticic, Assoc Prof I Hasanoglu. 👉 brnw.ch/21x4vKJ @escmid.bsky.social #WorldHepatitisDay
011
Reposted by Oana Sandulescu
European Centre for Disease Prevention and Control @ecdc.europa.eu · 28/07/2026
No one should die from a disease that is preventable, diagnosable and treatable. Yet around 5M people in Europe live with chronic hepatitis B or C, and almost 60,000 people die each year from liver disease linked to these infections. More information about the situation: bit.ly/WorldHepDay2026
bit.ly
World Hepatitis Day 2026: Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach
While Europe has made steady progress in preventing hepatitis B and C the region is set to miss the 2030 target to eliminate viral hepatitis as a public health threat.
11811
Reposted by Oana Sandulescu
European Centre for Disease Prevention and Control @ecdc.europa.eu · 28/07/2026
But gaps remain: ➡️ Hepatitis B vaccination coverage uneven across the EU/EEA ➡️ access to harm reduction services for people who inject drugs remains inadequate in many countries. Annual epidemiological report on Hepatitis B: www.ecdc.europa.eu/en/publicati... #Hepatitis #HepatitisB #HepatitisC
ecdc.europa.eu
Hepatitis B - Annual Epidemiological Report for 2024
For 2024, 30 EU/EEA countries reported 37 605 cases of hepatitis B virus (HBV) infection, corresponding to a crude rate of 7.5 cases per 100 000 population.
165
Reposted by Oana Sandulescu
European Centre for Disease Prevention and Control @ecdc.europa.eu · 28/07/2026
Effective solutions to control viral hepatitis already exist, including vaccination, harm reduction, testing and treatment. This #WorldHepatitisDay, the challenge is ensuring these life-saving interventions are accessible to everyone who needs them. bit.ly/WorldHepDay2026 #IDsky #EpiSky
056
Oana Sandulescu @oana-sandulescu.bsky.social · 09/07/2026
#MaPaCi2026, Tg Mures Multidisciplinary care begins by seeing the person beyond the diagnosis. For people living with viral hepatitis or HIV, trust and reducing stigma are essential parts of care. Medicine is strongest when knowledge, compassion, and collaboration come together. #WEEPIFoundation
052
Oana Sandulescu @oana-sandulescu.bsky.social · 12/06/2026
Amazing event, fantastic colleagues, insightful discussions! 👏👏
000
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 21/05/2026
One week left to register for the @escmid.bsky.social course: "Navigating infectious diseases in pregnancy", proudly supported by @esgvh.bsky.social. Keynote lectures from distinguished experts: @oana-sandulescu.bsky.social, Gülşen Özkaya Şahin, Heli Harvala. Register at the link: lnkd.in/dadZHyBA
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
011
Reposted by Oana Sandulescu
REVERSE Project @reverseproject.bsky.social · 30/03/2026
REVERSE joined the ID & HIV Dialogues conference in 🇷🇴! We presented our latest findings on: ✅ Reducing MDR bacterial infections through collaboration. ✅ Implementing stewardship frameworks that work. ✅ New evidence for managing carbapenem-resistant Gram-negatives. Discover REVERSE bit.ly/3Q8BgrZ
111
Oana Sandulescu @oana-sandulescu.bsky.social · 26/03/2026
An incredible 2 days at HIV Advanced Training Forum, Bucharest! Energy, interaction & case-based learning to advance HIV care. Inspired by our trainees & the high demand for this program. Thanks to our outstanding faculty & our sponsors Gilead Sciences and ViiV Healthcare.
242
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 25/03/2026
#ESGVH is proud to organize the #HIV Advanced Training Forum 2026 in Bucharest, led by Prof. @oana-sandulescu.bsky.social & Assoc. Prof. Juan Ambrosioni. A 2-day course empowering early-career clinicians with practical, evidence-based HIV care. @eacsociety.bsky.social @escmid.bsky.social
022
Oana Sandulescu @oana-sandulescu.bsky.social · 25/03/2026
HIV experts from 🇷🇴, 🇳🇱, 🇪🇸, 🇩🇪, 🇬🇧, 🇵🇱 gather in RO for the HIV Advanced Training Forum. International program for young clinicians, endorsed by leading ID organizations. Proud to share knowledge, connect and support the next generation shaping HIV care. @eacsociety.bsky.social @escmid.bsky.social
041
Oana Sandulescu @oana-sandulescu.bsky.social · 05/03/2026
Starting now! Still time to join us: us06web.zoom.us/webinar/regi... @escmid.bsky.social @esgvh.bsky.social #UCHID
us06web.zoom.us
Welcome! You are invited to join a webinar: A Collaborative session between ESGVH & UCHID: Treatment for All in HBV: Pros & Cons. After registering, you will receive a confirmation email about joining...
Session Schedule: Welcome message by the head of both groups (10 m) First speaker: Prof: Gamal Esmat Cairo University, Egypt Treatment for All in HBV: Pros & Cons (20 m) Second speaker: Prof. Oana San...
000
Oana Sandulescu @oana-sandulescu.bsky.social · 07/02/2026
For 3 days, 🇷🇴 Romania was an international hub for #IPC training, part of the #EUCIC certificate Participants from 10 countries came together: 🇬🇧 🇩🇪 🇮🇹 🇪🇸 🇸🇮 🇧🇦 🇲🇹 🇹🇷 🇰🇷 🇷🇼 to explore how molecular&bioinformatics tools support surveillance and improve patient safety @escmid.bsky.social @eucic.bsky.social
031
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 06/02/2026
Delighted to partner with #UCHID for this impactful webinar on Treatment for all in HBV. #ESGVH is represented by our Chair, Prof @oana-sandulescu.bsky.social, and EC members Prof Nabil, Assoc Prof Hasanoglu. 📅 March 5, 11 PM CET 🔗 Register: us06web.zoom.us/webinar/regi... @escmid.bsky.social
011
Reposted by Oana Sandulescu
Ecraid @ecraid.bsky.social · 16/01/2026
📢 Ecraid Foundation Science Meeting: registration deadline extended! Join industry leaders, researchers, clinicians & policy experts to discuss cutting-edge science & collaboration in infectious diseases and clinical research. Accredited by NVMM (11 points) and ABIC www.eventbrite.nl/e/ecraid-fou...
eventbrite.nl
Ecraid Foundation Science Meeting
Engage with Europe’s first dedicated clinical research network for infectious diseases, meet ID experts and foster collaboration.
011
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 18/12/2025
📢 Join us for a #HepDelta webinar by world class speakers: #ESGVH 🤝 #SOLDA Hepatitis Delta: Challenges in Diagnosis & Management 💻 Online, today ⏰ 11 a.m. CET 🔗 Register for free: lnkd.in/g5AXFGdv #WebSymposium #ViralHepatitis @esgvh.bsky.social @escmid.bsky.social @oana-sandulescu.bsky.social
022
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 23/11/2025
#ESGVH message for #HepTestWeek 25: Testing saves lives. Awareness drives change. Action moves us forward. 🩺 Early diagnosis = timely treatment 🤝 Normalize testing, reduce stigma 🌍 Elimination is possible if we act now @escmid.bsky.social @worldhepalliance.bsky.social @oana-sandulescu.bsky.social
033
Oana Sandulescu @oana-sandulescu.bsky.social · 22/10/2025
🌍 Delighted to speak at #ESWI2025 in Valencia on how #infection can decompensate, unmask, or trigger #NCDs — a vital link we see daily in practice. 💡 Time to act: Let's prevent NCDs by preventing infections. #InfectiousDiseases #IDC #PublicHealth #Influenza #Prevention @eswinfluenza.bsky.social
152
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 19/10/2025
🌍 Proud of #ESGVH Chair Prof @oana-sandulescu.bsky.social for her inspiring role at #EACS2025 in Paris! 🎓🎤 Now Vice Chair of #YING, she’s advancing education & building bridges 🌉 between #ESCMID 🦠 and #EACS 🧬 for a healthier, more connected future 🌐💫 @escmid.bsky.social @eacsociety.bsky.social
031
Oana Sandulescu @oana-sandulescu.bsky.social · 18/10/2025
Also at #EACS2025 🇫🇷✨ Privileged to speak on advancing #HIV #PrEP equity 🌍 and improving access 💉💊 #EACS2025 was not only a platform for learning 📚 and collaboration 🙌 but also a chance to reconnect with friends 🤗 Grateful to be part of this passionate community 🤍 @eacsociety.bsky.social
072
Oana Sandulescu @oana-sandulescu.bsky.social · 18/10/2025
#EACS2025 🇫🇷✨ It was a pleasure co-organizing the Educational Course with the incredible #YING Faculty. Excited to step in as #EACS #YING Vice Chair and work with our new Chair Jose Bernardino following in the steps of @tristanjbarber.bsky.social 🙌 @eacsociety.bsky.social #HIV #GlobalHealth
032
Reposted by Oana Sandulescu
European AIDS Clinical Society @eacsociety.bsky.social · 16/10/2025
#EACS2025- Oana Sandulescu is talking about advancing #PrEP equity across #Europe by integrating policy, community and clinical approaches, integrating PrEP delivery, reaching underserved populations, simplifying access and supporting community-led and peer-based models.
063
Reposted by Oana Sandulescu
Jesica Abadia @jessabbey.bsky.social · 16/10/2025
PrEP around Europe.. are we leaving anyone behind? @oana-sandulescu.bsky.social #EACS2025 there are a lot of hidden barriers to Access, are we doing our best to mitigate them?
Diapositiva que resume barreras ocultas para el acceso a PrEP
022
Reposted by Oana Sandulescu
European AIDS Clinical Society @eacsociety.bsky.social · 15/10/2025
#EACS2025 Marie-Angelique de Scheerder presenting current data on #HIV and #weight. Lifestyle intervention remains the cornerstone, however GLP-1 analogues appear to be safe and effective for reduction of central #obesity.
042
Oana Sandulescu @oana-sandulescu.bsky.social · 15/10/2025
✨ Great start to #EACS2025 🎤 Amazing @tristanjbarber.bsky.social opens the pre-conf Ed Course that features a stellar mix: clinical cases + research 🔍 🧬 Malignancies 🦠 Virology 💭 Stigma ⚖️ Weight 🔮 Future of ART 🎓 Research & Education Excited for what’s ahead for #YING! 🚀 @eacsociety.bsky.social
273
Oana Sandulescu @oana-sandulescu.bsky.social · 09/10/2025
A pleasure to host the CEE meeting again in Romania, almost 10 years after the last edition in Bucharest. Looking forward to meaningful scientific exchange with experts from all over Europe. Join us by registering at the link below: academicmedicaleducation.com/programs/9th...
academicmedicaleducation.com
9th Central and Eastern European Meeting on Viral Hepatitis and HIV 2025
In-Person event focusing on HIV, COVID-19, HIV, Viral Hepatitis and Liver Disease. 2025-11-05 to 2025-11-06 in Bucharest
000
Oana Sandulescu @oana-sandulescu.bsky.social · 12/09/2025
A truly insightful exchange of knowledge with outstanding experts at the ESCMID #VaccinesConference @escmid.bsky.social Gulsen Ozkaya Sahin @casandrabulescu.bsky.social Susanne Gjeruldsen Dudman @oana-sandulescu.bsky.social Zeinab Nabil Mario Mondelli @taescmid.bsky.social @esgvh.bsky.social
011
Oana Sandulescu @oana-sandulescu.bsky.social · 12/09/2025
✨ Day 3 at @escmid.bsky.social #VaccinesConference Now up 👉 Eliminating Hepatitis by 2030: How Vaccines are Key to Achieving WHO’s Vision? Fascinating fresh perspectives from international experts 🌍 Honored to join this outstanding panel and contribute to a thought-provoking conversation 🙌✨
111
Oana Sandulescu @oana-sandulescu.bsky.social · 11/09/2025
Delighted to have chaired this session at the #VaccinesConference by @escmid.bsky.social Covering updates in CMV, RSV, and pertussis, the take home message is: Use the vaccines we have and foster research for future developments in vaccinology. 💉🔬 Now up, a thought provoking keynote lecture.
011
Oana Sandulescu @oana-sandulescu.bsky.social · 04/09/2025
An utter delight to have been part of this. Always happy when I can contribute to training future generations of professionals to support adequate vaccination practices. #Prevention, #Vaccination, #Health
010
Reposted by Oana Sandulescu
Academic Medical Education @academicmededu.bsky.social · 21/08/2025
Liver cancer? #LongActing drugs? #Epidemiology? Drug resistance? Coinfections or multimorbidity? Share your findings at the 9th Central and Eastern European Meeting on #ViralHepatitis and #HIV 2025! Abstracts open until Fri, 19 Sep 🔗 amededu.co/4fkiOWa #CEEViralHepHIV #IDSky #MedSky #MedEd
011
Oana Sandulescu @oana-sandulescu.bsky.social · 30/07/2025
A pleasure to be part of the scientific committee for this event. Make sure to join us in Bucharest on 5-6 Nov and submit your abstracts by 19 Sep to showcase your research. amededu.co/45sJDE0
amededu.co
9th Central and Eastern European Meeting on Viral Hepatitis and HIV 2025
In-Person event focusing on HIV, HIV, Viral Hepatitis and Liver Disease, RSV, COVID-19. 2025-11-05 to 2025-11-06 in Bucharest
021
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 28/07/2025
🟡Today is #WorldHepatitisDay @esgvh.bsky.social stands for stigma-free equitable access to viral hepatitis testing & treatment. 🎥Missed our webinar with @ecdc.europa.eu, @whoeurope.bsky.social & @worldhepalliance.bsky.social? 👉Replay now: lnkd.in/dmJKN85U #Hepatitis #WHD2025 @escmid.bsky.social
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
032
Reposted by Oana Sandulescu
ESGVH (ESCMID Study Group for Viral Hepatitis) @esgvh.bsky.social · 18/07/2025
📢 Call to young researchers: On behalf of the @esgvh.bsky.social Publication Subcommittee, Prof Zeinab Nabil is assessing challenges for early-career CM and ID physicians in research. If you are an early career MD, fill out the survey below: lnkd.in/dkQbmWqQ @escmid.bsky.social
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
011
Oana Sandulescu @oana-sandulescu.bsky.social · 11/07/2025
🚨 Call for Papers! Extra Baggage: Preparing the Traveler with Medical Comorbidities 🌍✈️ Collection in Tropical Diseases, Travel Medicine & Vaccines (IF 2.2) Submit you work on chronic illness, travel prep, vaccines, & more. 📩 Info: bit.ly/3EBo9Kw #TravelMedicine @springernature.com
021
Oana Sandulescu @oana-sandulescu.bsky.social · 03/07/2025
An utter delight to be co-organizing this alongside such brilliant professionals! Join us today at 11.00 CET. 🔗 Register now: lnkd.in/dUipyqcp @esgvh.bsky.social @ecdc.europa.eu @worldhepalliance.bsky.social @escmid.bsky.social
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
000
Reposted by Oana Sandulescu
European AIDS Clinical Society @eacsociety.bsky.social · 30/06/2025
We are at the @europarl.europa.eu for the EP Roundtable hosted by MEP @krzysztofsmiszek.bsky.social Today's discussions bring together policymakers, clinicians, researchers & community voices to address persistent barriers in the #HIV response and shape a united way forward.
022
Reposted by Oana Sandulescu
European AIDS Clinical Society @eacsociety.bsky.social · 25/06/2025
📢 Applications are open for the European Diploma in #HIV Medicine! Designed for medical professionals, the exam supports high standards in HIV care across Europe. 📆 Apply by 9 July 📝 Exam: 25 Sept 🔗 Learn more: ow.ly/xOIO50W9SLq
012
Oana Sandulescu @oana-sandulescu.bsky.social · 12/06/2025
Looking back on two incredible days at the HIV Advanced Training Forum 🇷🇴 - truly enriching experience alongside brilliant colleagues. We journeyed through the complexities and nuances of HIV management, setting the foundation for responsive and relevant care. #MedicalEducation #HIVCare Post 1/3
122